Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity

被引：0
|
作者：
Chetty, Ashwin K. [1 ]
Khunte, Mihir [2 ]
Chen, Alissa S. [3 ]
Jastreboff, Ania M. [4 ]
Krumholz, Harlan M. [5 ]
Lu, Yuan [5 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI USA
[3] Yale Sch Med, Dept Internal Med, Natl Clinician Scholars Program, New Haven, CT USA
[4] Yale Sch Med, Yale Obes Res Ctr Y Weight, Dept Internal Med Endocrinol, New Haven, CT USA
[5] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2024年
关键词：
D O I：
10.1007/s11606-024-09178-8
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1467 / 1469
页数：3
相关论文
共 50 条
  • [41] EFFECTIVENESS OF ANTI-OBESITY MEDICATIONS IN "REAL WORLD" CLINICAL PRACTICE
    Calderon, Gerardo
    Hurtado, Maria D.
    Valencia, Oscar A. Garcia
    Gonzalez-Izundegui, Daniel
    Sharma, Mayank
    Shah, Meera
    Hurley, Daniel L.
    Abu-Lebdeh, H. S.
    Schmitz, Kristine
    Clark, Matthew
    Grothe, Karen
    Mundi, Manpreet
    Jensen, Michael D.
    Abu Dayyeh, Barham K.
    Collazo-Clavell, Maria L.
    Camilleri, Michael
    Acosta, Andres
    GASTROENTEROLOGY, 2019, 156 (06) : S931 - S931
  • [42] Ischemic colitis after mesotherapy combined with anti-obesity medications
    Jong Bin Kim
    Won Moon
    Seun Ja Park
    Moo In Park
    Kyu-Jong Kim
    Jae Nam Lee
    Seong Joo Kang
    Lee La Jang
    Hee Kyung Chang
    World Journal of Gastroenterology, 2010, 16 (12) : 1537 - 1540
  • [43] Anti-obesity Medications: Ethical, Policy, and Public Health Concerns
    Klitzman, Robert
    Greenberg, Henry
    HASTINGS CENTER REPORT, 2024, 54 (03) : 6 - 10
  • [44] Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    Giouleme, Olga
    Germanidis, Georgios S.
    Goulas, Antonis
    CURRENT OBESITY REPORTS, 2022, 11 (03) : 166 - 179
  • [45] A narrative review of anti-obesity medications for obese patients with osteoarthritis
    Oo, Win Min
    Mobasheri, Ali
    Hunter, David J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (12) : 1381 - 1395
  • [46] THE RELATIVE VALUE OF ANTI-OBESITY MEDICATIONS COMPARED TO SIMILAR THERAPIES
    Kim, N.
    Estrada, J.
    Chow, I
    Ruseva, A.
    Ramasamy, A.
    Burudpakdee, C.
    Blanchette, C. M.
    VALUE IN HEALTH, 2022, 25 (07) : S348 - S349
  • [47] Ischemic colitis after mesotherapy combined with anti-obesity medications
    Kim, Jong Bin
    Moon, Won
    Park, Seun Ja
    Park, Moo In
    Kim, Kyu-Jong
    Lee, Jae Nam
    Kang, Seong Joo
    Jang, Lee La
    Chang, Hee Kyung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (12) : 1537 - 1540
  • [48] The Relative Value of Anti-Obesity Medications Compared to Similar Therapies
    Kim, Nina
    Estrada, Joaquin
    Chow, Isabella
    Ruseva, Aleksandrina
    Ramasamy, Abhilasha
    Burudpakdee, Chakkarin
    Blanchette, Christopher M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 51 - 62
  • [49] Weight Loss After Receiving Anti-Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population-Based Cohort Study
    Wei, Jie
    Wang, Yilun
    Dalbeth, Nicola
    Xie, Junqing
    Wu, Jing
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    ARTHRITIS & RHEUMATOLOGY, 2024,
  • [50] Factors Associated with Prescription of Anti-Obesity and GLP-1 RA Medications in People with Obesity
    Gasoyan, Hamlet
    Schulte, Rebecca
    Le, Phuc
    Pfoh, Elizabeth
    Rothberg, Michael
    OBESITY, 2023, 31 : 179 - 179
12345